| Style | Citing Format |
|---|---|
| MLA | Bikdeli B, et al.. "Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies." Thrombosis Research, vol. 196, no. , 2020, pp. 382-394. |
| APA | Bikdeli B, Talasaz AH, Rashidi F, Sharifkashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, Dabbagh A, Beigmohammadi MT, Payandemehr P, Yadollahzadeh M, Riahi T, Khalili H, Jamalkhani S, Rezaeifar P, Abedini A, Lookzadeh S, Shahmirzaei S, Tahamtan O, ... Sadeghipour P (2020). Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies. Thrombosis Research, 196(), 382-394. |
| Chicago | Bikdeli B, Talasaz AH, Rashidi F, Sharifkashani B, Farrokhpour M, Bakhshandeh H, Sezavar H, et al.. "Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies." Thrombosis Research 196, no. (2020): 382-394. |
| Harvard | Bikdeli B et al. (2020) 'Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies', Thrombosis Research, 196(), pp. 382-394. |
| Vancouver | Bikdeli B, Talasaz AH, Rashidi F, Sharifkashani B, Farrokhpour M, Bakhshandeh H, et al.. Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies. Thrombosis Research. 2020;196():382-394. |
| BibTex | @article{ author = {Bikdeli B and Talasaz AH and Rashidi F and Sharifkashani B and Farrokhpour M and Bakhshandeh H and Sezavar H and Dabbagh A and Beigmohammadi MT and Payandemehr P and Yadollahzadeh M and Riahi T and Khalili H and Jamalkhani S and Rezaeifar P and Abedini A and Lookzadeh S and Shahmirzaei S and Tahamtan O and Matin S and Amin A and Parhizgar SE and Jimenez D and Gupta A and Madhavan MV and Parikh SA and Monreal M and Hadavand N and Hajighasemi A and Maleki M and Sadeghian S and Mohebbi B and Piazza G and Kirtane AJ and Lip GYH and Krumholz HM and Goldhaber SZ and Sadeghipour P}, title = {Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies}, journal = {Thrombosis Research}, volume = {196}, number = {}, pages = {382-394}, year = {2020} } |
| RIS | TY - JOUR AU - Bikdeli B AU - Talasaz AH AU - Rashidi F AU - Sharifkashani B AU - Farrokhpour M AU - Bakhshandeh H AU - Sezavar H AU - Dabbagh A AU - Beigmohammadi MT AU - Payandemehr P AU - Yadollahzadeh M AU - Riahi T AU - Khalili H AU - Jamalkhani S AU - Rezaeifar P AU - Abedini A AU - Lookzadeh S AU - Shahmirzaei S AU - Tahamtan O AU - Matin S AU - Amin A AU - Parhizgar SE AU - Jimenez D AU - Gupta A AU - Madhavan MV AU - Parikh SA AU - Monreal M AU - Hadavand N AU - Hajighasemi A AU - Maleki M AU - Sadeghian S AU - Mohebbi B AU - Piazza G AU - Kirtane AJ AU - Lip GYH AU - Krumholz HM AU - Goldhaber SZ AU - Sadeghipour P TI - Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies JO - Thrombosis Research VL - 196 IS - SP - 382 EP - 394 PY - 2020 ER - |